10th patient enrolled in INSPIRE study: 6 highlights

Cambridge, Mass.-based InVivo Therapeutics enrolled a new patient into its INSPIRE study, which tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.

Advertisement

Here are six highlights:

 

1. The newly enrolled patient suffered a T8-9 fracture dislocation injury.

 

2. Charlotte, N.C.-based Carolinas Medical Center enrolled the patient.  

 

3. Domagoj Coric, MD, of Carolina Neurosurgery and Spine Associates and chief of neurosurgery at the Carolinas Medical Center, implanted the Neuro-Spinal Scaffold into the patient. Dr. Coric’s partner, Samuel Chewning, MD, helped with the procedure.

 

4. Drs. Coric and Chewning implanted the device about 19 hours post-injury.

 

5. Dr. Coric and William Bockenek, MD, serve as co-principal investigators at the clinical site.

 

6. This patient marks the 10th patient enrolled and in follow up. The INSPIRE is designed to enroll 20 patients.

 
More articles on devices:
What Stryker CEO Kevin Lobo said on CNBC: 7 key quotes on healthcare, business & the future
Providence Medical Technology receives $10.5M new equity financing — 5 points
Stavros Vizirgianakis to lead Misonix as new president, CEO: 5 things to now

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.